pharma · Hepatocellular Carcinoma · Obesity
Hospital Authority
Hospital Authority, Hong Kong
Hospital Authority clinical programs — 27 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- Hospital Authority Building, 147B Argyle Street, Kowloon, Hong Kong, 852, HK, CN
- Founded
- 1991
- Employees
- 12,669
- Programs
- 322
- Drugs
- 301
- Patents
- 0
Hospital Authority projects
27 ClinicalTrials.gov programs sponsored by Hospital Authority.
Hospital Authority has 27 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
AZD5363+Olaparib+Durvalumab
Hospital Authority, Hong Kong
Solid Tumor, Adult
1 trial -
Autologous Natural Killer Cell Therapy
Hospital Authority, Hong Kong
Hepatocellular Carcinoma
1 trial -
Biological: PD-1
Hospital Authority, Hong Kong
Advanced Solid Tumor
1 trial -
CAR T-cell therapy
Hospital Authority, Hong Kong
Lymphoblastic Leukemia, Acute, Childhood
1 trial -
Cordyceps cicadae extract
Hospital Authority, Hong Kong
Myopia
1 trial -
Digoxin
Hospital Authority, Hong Kong
Healthy
1 trial -
Drugs administration
Hospital Authority, Hong Kong
Rotator Cuff Tears of the Shoulder
1 trial -
Extraluminal use of Univent bronchial Blocker
Hospital Authority, Hong Kong
Therapeutic Procedural Complication
1 trial -
Fospropofol disodium
Hospital Authority, Hong Kong
Drug Safety
1 trial -
HBV mRNA vaccine
Hospital Authority, Hong Kong
Hepatocellular Carcinoma (HCC)
1 trial -
INAVAC (Vaksin Merah Putih - UA- SARS CoV-2 (Vero Cell Inactivated) 5 μg
Hospital Authority, Hong Kong
COVID-19 Pandemic
1 trial -
Implantation
Hospital Authority, Hong Kong
Bone Loss
1 trial -
Intercerebral implantation of allogenic CD34+ stem cell
Hospital Authority, Hong Kong
Ischemic Stroke
1 trial -
Interleukin, NK cells
Hospital Authority, Hong Kong
Metastatic Nasopharyngeal
1 trial -
Larotrectinib
Hospital Authority, Hong Kong
High Grade Glioma
1 trial -
MTL-CEBPA
Hospital Authority, Hong Kong
Advanced Hepatocellular Carcinoma
1 trial -
Motion analysis of patients
Hospital Authority, Hong Kong
Leg Length Discrepancy
1 trial -
Neoadjuvant chemotherapy
Hospital Authority, Hong Kong
Squamous Cell Carcinoma of Oral Cavity
1 trial -
OPB-51602
Hospital Authority, Hong Kong
Nasopharyngeal Carcinoma
1 trial -
Oxidized regenerated cellulose(ORC)
Hospital Authority, Hong Kong
Thyroidectomy
1 trial -
PRG-1801
Hospital Authority, Hong Kong
Immune Thrombocytopenia
1 trial -
Paclitaxel
Hospital Authority, Hong Kong
Ovarian Cancer
1 trial -
SNUCPT08_GCPGC
Hospital Authority, Hong Kong
Healthy
1 trial -
Silodosin
Hospital Authority, Hong Kong
Benign Prostatic Hyperplasia
1 trial -
Tissue Plasminogen Activator (tPA)
Hospital Authority, Hong Kong
Peritoneal Dialysis
1 trial -
UTAA91 injection
Hospital Authority, Hong Kong
Rheumatoid Arthritis (RA)
1 trial -
Vaksin Merah Putih - UA SARS-CoV-2 (Vero Cell Inactivated) 5 µg
Hospital Authority, Hong Kong
COVID-19 Pandemic
1 trial
Frequently asked questions
How many clinical projects does Hospital Authority have?
27 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.